Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 1463 entries
View as:

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT05207904 Org: User:
Start: 06/17/21 End: 06/30/23 Due: 06/30/24

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Phase: N/A Priority: Normal
NCT ID: NCT06730308 Org: User:
Start: 11/20/24 End: 11/19/28 Due: 11/19/29

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05555316 Org: User:
Start: 11/10/19 End: 11/30/23 Due: 11/30/24

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT06624696 Org: User:
Start: 11/12/24 End: 09/30/26 Due: 09/30/27

Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06630780 Org: User:
Start: 10/20/24 End: 12/31/29 Due: 12/31/30

MItral Regurgitation Risk Assessment and CLinical ModElling

Phase: N/A Priority: Normal
NCT ID: NCT06876883 Org: User:
Start: 06/15/16 End: 06/15/30 Due: 06/15/31

Validation of a Smartphone App for Anemia Screening Among General Population

Phase: N/A Priority: Normal
NCT ID: NCT05490823 Org: User:
Start: 12/01/18 End: 12/01/22 Due: 12/01/23

Validation of a Universal Cataract Intelligence Platform

Phase: N/A Priority: Normal
NCT ID: NCT03623971 Org: User:
Start: 01/01/13 End: 06/01/17 Due: 06/01/18

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Phase: N/A Priority: Normal
NCT ID: NCT05587374 Org: User:
Start: 08/01/23 End: 08/01/29 Due: 08/01/30

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT03067493 Org: User:
Start: 07/25/17 End: 03/31/23 Due: 03/31/24

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02031939 Org: User:
Start: 01/31/14 End: 12/31/25 Due: 12/31/26

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05980689 Org: User:
Start: 10/24/23 End: 01/31/25 Due: 01/31/26

Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02969681 Org: User:
Start: 01/31/17 End: 12/30/20 Due: 12/30/21

Office Based Vergence and Accommodative Therapy and Intermittent Exotropia

Phase: N/A Priority: Normal
NCT ID: NCT03321838 Org: User:
Start: 11/01/17 End: 12/30/18 Due: 12/30/19

Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort

Phase: N/A Priority: Normal
NCT ID: NCT05682794 Org: User:
Start: 01/31/14 End: 10/31/22 Due: 10/31/23

Improve the Treatment of Thoracic Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01137123 Org: User:
Start: 04/30/10 End: 12/31/20 Due: 12/31/21

Retinoic Acid Supplementation and Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT02497833 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00721773 Org: User:
Start: 09/30/08 End: 10/31/14 Due: 10/31/15

Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06099951 Org: User:
Start: 11/01/23 End: 09/01/27 Due: 09/01/28

ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02874651 Org: User:
Start: 10/31/16 End: 08/27/20 Due: 08/27/21

An Innovative Method Fluid-jet to to Remove Residual Lens Fibers

Phase: N/A Priority: Normal
NCT ID: NCT03605160 Org: User:
Start: 01/01/18 End: 01/01/23 Due: 01/01/24

A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06143579 Org: User:
Start: 12/15/23 End: 12/31/26 Due: 12/31/27

Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02595554 Org: User:
Start: 11/30/15 End: 12/31/20 Due: 12/31/21

Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue

Phase: N/A Priority: Normal
NCT ID: NCT03048305 Org: User:
Start: 02/01/17 End: 01/31/23 Due: 01/31/24

the Real-world Data of Risk Factor and Its Prognosis in PREmature Coronary ARtery DIseAse Study

Phase: N/A Priority: Normal
NCT ID: NCT06695182 Org: User:
Start: 10/31/13 End: 03/31/27 Due: 03/31/28